TNG.PA Gross Margin

The Gross Margin of Transgene SA (TNG.PA) is -700.96%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

TNG.PA Gross Margin - Historical Value

Date	Value
2024-12-31	-700.96%

TNG.PA Gross Margin - Peers Comparison

Ticker	Name	Value
BONEX.ST	Bonesupport Holding AB	92.60%
IPH.PA	Innate Pharma SA	75.79%
NANO.PA	Nanobiotix SA	100.00%
PA8.DE	Paion AG	94.10%
ADXN.SW	Addex Therapeutics Ltd	-958.33%
B8F.DE	Biofrontera AG	80.64%
BIOPOR.CO	Bioporto A/S	67.68%
DBV.PA	Dbv Technologies SA	83.62%
DNL.L	Diurnal Group PLC	78.16%
KAN.ST	Kancera AB	70.00%
ALONX.PA	Onxeo SA	64.38%
AZT.OL	Arcticzymes Technologies ASA	94.27%
BML.WA	Synthaverse SA	55.44%
ERYP.PA	Erytech Pharma SA	7775.20%
SIGHT.PA	Gensight Biologics SA	188.37%
ABVX.PA	Abivax SA	-19700.00%
BIO.MC	Biosearch SA	39.64%
COX.PA	Nicox SA	100.00%
OASM.ST	Oasmia Pharmaceutical AB	-6845.60%
VICO.ST	Vicore Pharma Holding AB	197.14%
ACOU.ST	Acousort AB	100.72%
DEST.L	Destiny Pharma PLC	7775.20%
ISOFOL.ST	Isofol Medical AB (publ)	-4773.23%
IVA.PA	Inventiva SA	146.31%
VLA.PA	Valneva SE	41.89%
ALNOV.PA	Novacyt SA	163.39%
ALPHA.PA	Pharnext SA	-14187.50%
CIR.L	Circassia Group PLC	68.10%
OKYO.L	OKYO Pharma Ltd	7775.20%
OPTI.L	OptiBiotix Health PLC	38.05%
ALCLS.PA	Cellectis SA	6.96%
BIO.WA	Bioton SA	31.21%
HBC.OL	Hofseth Biocare ASA	34.13%